Biotricity Inc. (BTCY): EPS (Diluted)
-$0.12
Year ended 2026-03-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | -$0.12 | n/m | 2026-07-14, From 2025-04-01 |
| 2025-03-31 | -$0.56 | n/m | 2026-07-14, From 2024-04-01 |
| 2024-03-31 | -$1.66 | n/m | 2025-07-18, From 2023-04-01 |
| 2023-03-31 | -$2.26 | n/a | 2024-06-27, From 2022-04-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Biotricity Inc. (BTCY) | 2026-03-31 | -$0.12 | n/m |
| Profound Medical Corp. (PROF) | 2025-12-31 | $1.41 | +25.9% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | -$3.81 | n/m |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | -$2.07 | n/m |
| Nephros Inc (NEPH) | 2025-12-31 | $0.11 | +1000.0% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | -$1.89 | n/m |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | -$0.29 | n/m |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $10.12 | -17.5% |
| Nexgel, Inc. (NXGL) | 2025-12-31 | -$0.38 | n/m |
Compare BTCY, PROF, ALUR, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗